Exact Mass: 275.1117

Exact Mass Matches: 275.1117

Found 50 metabolites which its exact mass value is equals to given mass value 275.1117, within given mass tolerance error 4.0E-5 dalton. Try search metabolite list with more accurate mass tolerance error 8.0E-6 dalton.

Gamma-glutamylglutamine

(2S)-2-[(4S)-4-amino-4-carboxybutanamido]-4-carbamoylbutanoic acid

C10H17N3O6 (275.1117)


N2-gamma-Glutamylglutamine, also known as gamma-L-Glu-L-Gln or L-gamma-glutamyl-L-glutamine, belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. N2-gamma-Glutamylglutamine is a very strong basic compound (based on its pKa). N2-gamma-Glutamylglutamine is a dipeptide obtained from the condensation of the gamma-carboxy group of glutamic acid with the alpha-amino group of glutamine. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. gamma-Glutamylglutamine has been identified in plasma and cerebrospinal fluid from hyperammonaemic patients. [HMDB] H-γ-Glu-Gln-OH is a hydrophilic peptide and can be conjugated to drugs. The carrier composed of H-γ-Glu-Gln-OH has the characteristics of high water solubility and drug-loading capacity, good biocompatibility, low toxicity, improved tumor targeting ability, and anti-tumor efficacy[1].

   

N-Succinyl-L-citrulline

N-Succinyl-L-citrulline

C10H17N3O6 (275.1117)


   

Glutamylglutamine

(2S)-2-{[(2S)-2-amino-4-carboxy-1-hydroxybutylidene]amino}-4-(C-hydroxycarbonimidoyl)butanoate

C10H17N3O6 (275.1117)


Glutamylglutamine is a dipeptide composed of glutamate and glutamine, and is a proteolytic breakdown product of larger proteins. It belongs to the family of N-acyl-alpha amino acids and derivatives. These are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. Glutamylglutamine is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Norophthalmic acid

(2S)-2-Amino-4-{[(1S)-1-[(carboxymethyl)-C-hydroxycarbonimidoyl]ethyl]-C-hydroxycarbonimidoyl}butanoate

C10H17N3O6 (275.1117)


Norophthalmic acid (y-glutamyl-alanyl-glycine) is an analogue of glutathione (L-cysteine replaced by L-alanine) isolated from crystalline lens. [HMDB] Norophthalmic acid (y-glutamyl-alanyl-glycine) is an analogue of glutathione (L-cysteine replaced by L-alanine) isolated from crystalline lens.

   

Glutaminylglutamic acid

(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]pentanedioic acid

C10H17N3O6 (275.1117)


Glutaminylglutamic acid is a dipeptide composed of glutamine and glutamic acid. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Glutamyl-Gamma-glutamate

2-Amino-4-[(2-amino-4-carboxybutanoyl)-C-hydroxycarbonimidoyl]butanoate

C10H17N3O6 (275.1117)


Glutamyl-Gamma-glutamate is a dipeptide composed of glutamate and gamma-glutamate. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

N-gamma-Glutamylglutamine

(2S)-2-Amino-4-{[(4S)-4-amino-4-carboxybutanoyl]-C-hydroxycarbonimidoyl}butanoate

C10H17N3O6 (275.1117)


N-gamma-Glutamylglutamine is a dipeptide obtained from condensation of the gamma-carboxy group of glutamic acid with the side-chain amide group of glutamine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

alpha-deS-Glutathione|H-alpha-Glu-Ala-Gly-OH|norophthalmic acid

alpha-deS-Glutathione|H-alpha-Glu-Ala-Gly-OH|norophthalmic acid

C10H17N3O6 (275.1117)


   
   
   
   
   
   

gamma-Glutamylglutamine

gamma-Glutamylglutamine

C10H17N3O6 (275.1117)


H-γ-Glu-Gln-OH is a hydrophilic peptide and can be conjugated to drugs. The carrier composed of H-γ-Glu-Gln-OH has the characteristics of high water solubility and drug-loading capacity, good biocompatibility, low toxicity, improved tumor targeting ability, and anti-tumor efficacy[1].

   
   

H-gamma-glutamyl-glutamine

H-gamma-glutamyl-glutamine

C10H17N3O6 (275.1117)


   
   
   
   
   
   
   
   

Norophthalmic acid

gamma-Glutamyl-alanyl-glycine

C10H17N3O6 (275.1117)


A tripeptide composed of L-glutamic acid, L-alanine, and glycine residues joined in sequence by peptide linkages.

   

3773-08-8

(2S)-2-amino-5-[[(1S)-2-(carboxymethylamino)-2-keto-1-methyl-ethyl]amino]-5-keto-valeric acid

C10H17N3O6 (275.1117)


   

N-gamma-Glutamylglutamine

N-gamma-Glutamylglutamine

C10H17N3O6 (275.1117)


   

4-Amino-5-[(4-amino-1-carboxy-4-oxobutyl)amino]-5-oxopentanoic acid

4-Amino-5-[(4-amino-1-carboxy-4-oxobutyl)amino]-5-oxopentanoic acid

C10H17N3O6 (275.1117)


   

alpha-D-ManNAc3NAmA

alpha-D-ManNAc3NAmA

C10H17N3O6 (275.1117)


   

(2S,3S,4R,5S,6S)-5-acetamido-4-(1-aminoethylideneamino)-3,6-dihydroxyoxane-2-carboxylic acid

(2S,3S,4R,5S,6S)-5-acetamido-4-(1-aminoethylideneamino)-3,6-dihydroxyoxane-2-carboxylic acid

C10H17N3O6 (275.1117)


   

Ala-Ala-Asp

Ala-Ala-Asp

C10H17N3O6 (275.1117)


A tripeptide composed of two L-alanyl and an L-aspartic acid residue joined in sequence.

   
   
   
   
   
   
   
   
   

Norophthalamic acid

Norophthalamic acid

C10H17N3O6 (275.1117)


   

GLN-Glu

GLN-Glu

C10H17N3O6 (275.1117)


A dipeptide formed from L-glutamine and L-glutamic acid residues.

   

Glutamylglutamine

Glutamylglutamine

C10H17N3O6 (275.1117)


   

Glutamyl-Gamma-glutamate

Glutamyl-Gamma-glutamate

C10H17N3O6 (275.1117)


   

gamma-Glu-Gln

gamma-Glu-Gln

C10H17N3O6 (275.1117)


A dipeptide obtained by formal condensation of the gamma-carboxy group of glutamic acid with the amino group of glutamine

   

N(2)-Succinyl-citrulline

N(2)-Succinyl-citrulline

C10H17N3O6 (275.1117)


   

(2s)-2-amino-4-{[(1r)-1-(carboxymethyl-c-hydroxycarbonimidoyl)ethyl]-c-hydroxycarbonimidoyl}butanoic acid

(2s)-2-amino-4-{[(1r)-1-(carboxymethyl-c-hydroxycarbonimidoyl)ethyl]-c-hydroxycarbonimidoyl}butanoic acid

C10H17N3O6 (275.1117)


   

(2s)-2-amino-4-{[(1s)-1-(carboxymethyl-c-hydroxycarbonimidoyl)ethyl]-c-hydroxycarbonimidoyl}butanoic acid

(2s)-2-amino-4-{[(1s)-1-(carboxymethyl-c-hydroxycarbonimidoyl)ethyl]-c-hydroxycarbonimidoyl}butanoic acid

C10H17N3O6 (275.1117)


   

2-amino-4-{[1-(carboxymethyl-c-hydroxycarbonimidoyl)ethyl]-c-hydroxycarbonimidoyl}butanoic acid

2-amino-4-{[1-(carboxymethyl-c-hydroxycarbonimidoyl)ethyl]-c-hydroxycarbonimidoyl}butanoic acid

C10H17N3O6 (275.1117)


   

(2s)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxypropylidene]amino}-1-hydroxypropylidene]amino}butanedioic acid

(2s)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxypropylidene]amino}-1-hydroxypropylidene]amino}butanedioic acid

C10H17N3O6 (275.1117)


   

(2s)-2-{[(4s)-4-amino-4-carboxy-1-hydroxybutylidene]amino}-4-(c-hydroxycarbonimidoyl)butanoic acid

(2s)-2-{[(4s)-4-amino-4-carboxy-1-hydroxybutylidene]amino}-4-(c-hydroxycarbonimidoyl)butanoic acid

C10H17N3O6 (275.1117)